Fulgent Genetics (FLGT) Depreciation and Depletion (2017 - 2026)

Fulgent Genetics has reported Depreciation and Depletion for 10 years, with the latest figure at $5.0 million in Q2 2026.

• Quarterly Depreciation and Depletion rose 28.21% year-over-year to $5.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $16.8 million (up 8.39% YoY) and the FY2025 annual result came in at $15.7 million, down 4.27% from the prior year.
• Depreciation and Depletion improved to $5.0 million in Q2 2026 per FLGT's latest filing, from $3.9 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $7.6 million in Q3 2022 and troughed at $3.7 million in Q1 2022.
• A 5-year average of $4.7 million and a median of $4.0 million in 2023 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion soared 204.0% in 2022, then sank 43.42% in 2023.
• Over 5 years, Depreciation and Depletion stood at $7.6 million in 2022, then tumbled by 42.11% to $4.4 million in 2023, then dropped by 9.09% to $4.0 million in 2024, then changed by 0.0% to $4.0 million in 2025, then climbed by 25.0% to $5.0 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $5.0 million, $3.9 million, and $4.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.